Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Aars2em1flox/Cya
Common Name:
Aars2-flox
Product ID:
S-CKO-17519
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Aars2-flox
Strain ID
CKOCMP-224805-Aars2-B6J-VC
Gene Name
Aars2
Product ID
S-CKO-17519
Gene Alias
Aarsl; AlaRS; Gm89
Background
C57BL/6JCya
NCBI ID
224805
Modification
Conditional knockout
Chromosome
17
Phenotype
MGI:2681839
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Aars2em1flox/Cya mice (Catalog S-CKO-17519) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000024733
NCBI RefSeq
NM_198608
Target Region
Exon 1~5
Size of Effective Region
~3.9 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Aars2, or mitochondrial alanyl-tRNA synthetase 2, is one of the aminoacyl-tRNA synthases (ARSs) that performs amino acid transportation and is involved in protein synthesis within mitochondria [2]. It is responsible for charging tRNA-Ala with alanine during mitochondrial translation [5]. Mutations in Aars2 have been associated with a variety of disorders, indicating its importance in normal biological function. Genetic models, such as gene-knockout (KO) or conditional-knockout (CKO) mouse models, can potentially shed light on its exact functions in vivo.

Mutations in Aars2 are linked to autosomal recessive leukodystrophy, characterized by cognitive decline, ataxia, spasticity, and Parkinsonism [1]. In a case report, a 21-year-old male with Aars2-related leukodystrophy had compound heterozygous mutations in the Aars2 gene [1]. The emerging neurological spectrum of Aars2-associated disorders includes movement disorders, cognitive impairment, corticospinal signs, behavioral or psychiatric features, and eye signs, often with imaging evidence of leukoencephalopathy [3]. Premature ovarian failure is also frequent in females with Aars2 defects [3,6]. Additionally, Aars2 is upregulated in multiple cancers and may serve as a novel biomarker for prognosis and immunotherapy, with its deficiency inhibiting cell proliferation and migration in hepatocellular carcinoma (HCC) [2]. Aars2 also functions as a protein lysine lactyltransferase, and hypoxia-induced Aars2 accumulation can lactylate certain enzymes to limit oxidative phosphorylation [4]. In congenital cardiomyopathy, PCBP1 regulates the alternative splicing of Aars2, and loss of Pcbp1 or exon-16 skipping in Aars2 leads to heart developmental defects [5].

In conclusion, Aars2 is essential for mitochondrial protein synthesis and has a wide-reaching impact on various biological processes. Model-based research, especially KO/CKO mouse models, could potentially further clarify its role in diseases such as leukodystrophy, neurological disorders, ovarian insufficiency, cancer, and congenital cardiomyopathy. Understanding Aars2 provides insights into the underlying mechanisms of these diseases and may contribute to the development of new therapeutic strategies.

References:
1. Zhang, Xiao, Li, Jie, Zhang, Yanyan, Peng, Tao, Tian, Tian. 2022. AARS2-Related Leukodystrophy: a Case Report and Literature Review. In Cerebellum (London, England), 22, 59-69. doi:10.1007/s12311-022-01369-5. https://pubmed.ncbi.nlm.nih.gov/35084689/
2. Liu, Long, Gao, Jie, Liu, Xudong, Shi, Ji Hua, Zhang, Shuijun. 2023. AARS2 as a novel biomarker for prognosis and its molecular characterization in pan-cancer. In Cancer medicine, 12, 21531-21544. doi:10.1002/cam4.6682. https://pubmed.ncbi.nlm.nih.gov/37990642/
3. Parra, Sahyli Perez, Heckers, Stephan H, Wilcox, William R, Mcknight, Colin David, Jinnah, H A. 2021. The emerging neurological spectrum of AARS2-associated disorders. In Parkinsonism & related disorders, 93, 50-54. doi:10.1016/j.parkreldis.2021.10.031. https://pubmed.ncbi.nlm.nih.gov/34784527/
4. Mao, Yunzi, Zhang, Jiaojiao, Zhou, Qian, Xu, Wei, Zhao, Shimin. 2024. Hypoxia induces mitochondrial protein lactylation to limit oxidative phosphorylation. In Cell research, 34, 13-30. doi:10.1038/s41422-023-00864-6. https://pubmed.ncbi.nlm.nih.gov/38163844/
5. Lu, Yao Wei, Liang, Zhuomin, Guo, Haipeng, Chen, Hong, Wang, Da-Zhi. 2023. PCBP1 regulates alternative splicing of AARS2 in congenital cardiomyopathy. In bioRxiv : the preprint server for biology, , . doi:10.1101/2023.05.18.540420. https://pubmed.ncbi.nlm.nih.gov/37293078/
6. França, Monica Malheiros, Mendonca, Berenice Bilharinho. 2021. Genetics of ovarian insufficiency and defects of folliculogenesis. In Best practice & research. Clinical endocrinology & metabolism, 36, 101594. doi:10.1016/j.beem.2021.101594. https://pubmed.ncbi.nlm.nih.gov/34794894/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest